Related references
Note: Only part of the references are listed.Bone Mineral Density and Weight Changes in Adolescents Randomized to 3 Doses of Depot Medroxyprogesterone Acetate
Hannah L. H. Lange et al.
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2017)
Effect of age and estrogen on biochemical markers of bone turnover in postmenopausal women: a population-based study from Nepal
Bashu Dev Pardhe et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2017)
The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
Luiz Francisco Baccaro et al.
CLINICAL INTERVENTIONS IN AGING (2015)
Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover
Keijiro Mukaiyama et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2015)
Influence of Estrogen Therapy on Calcium, Phosphorus, and Other Regulatory Hormones in Postmenopausal Women: The MESA Study
Nisha Bansal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Transmenopausal changes in the trabecular bone structure
M. P. Akhter et al.
BONE (2007)
Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: Results from the women's health initiative randomized trial
Rebecca D. Jackson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women
R Lindsay et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials
K Peeyananjarassri et al.
CLIMACTERIC (2005)
Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial
GL Anderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial
JA Cauley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy
M Gambacciani et al.
MATURITAS (2003)
Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women
R Lindsay et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Pharmacologic doses of medroxyprogesterone may cause bone loss through glucocorticoid activity: An hypothesis
Y Ishida et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Epidemiology of fractures in England and Wales
TP Van Staa et al.
BONE (2001)
17β-estradiol (1 mg/day) continuously combined with dydrogesterone (5, 10 or 20 mg/day) increases bone mineral density in postmenopausal women
JC Stevenson et al.
MATURITAS (2001)
Share Paper
